RSS Feeds
Eczema Herpeticum as Complication of Darier's Disease
- JOHN F. VON WEISS, M.D.;
- SIDNEY KIBRICK, M.D., PH.D.; and
- WALTER F. LEVER, M.D.
- Requests for reprints should be addressed to John F. von Weiss, M.D., Dermatology Department, Boston Dispensary, 25 Bennet Street, Boston, Mass. 02111.
Excerpt
Darier's disease (keratosis follicularis) is an uncommon, genetically determined dermatosis (1) manifested by hyperkeratotic follicular papules and characterized by remissions and exacerbations. When the disease is active, the papules tend to coalesce to form verrucous, crusted areas. The disorder is generally aggravated by sunlight (2). Vitamin A, in high doses, often is beneficial (3).
Kaposi's varicelliform eruption is an acute febrile illness characterized by vesicopustules. It is caused by infection with either the herpes simplex or the vaccinia virus superimposed upon a pre-existing dermatosis. It is also designated as eczema herpeticum or eczema vaccinatum, depending upon the etiologic agent involved.
This 100-word excerpt has been provided in the absence of an abstract.
Summario in Interlingua
Es describite le occurrentia de eczema herpetic (eruption varicelliforme de Kaposi) post excessive insolation in un subjecto adulte con morbo de Darier. Le insolation causava un explosion del morbo de Darier le qual previemente habeva essite ben subjugate per medio de vitamin A. Quatro dies post le insolation extense eczema herpetic primari se disveloppava, predominantemente intra areas del morbo de Darier. Le diagnose esseva confirmate per studios virusal. Ben que eruption varicelliforme de Kaposi ha rarmente essite reportate in morbo de Darier, illo representa un complication potential de ille disordine. Exposition al virus de herpete simplice e vaccinia deberea esser evitate per patientes qui se trova in le stadio de morbo de Darier.
Article and Author Information
-
From the Department of Dermatology, Tufts University School of Medicine, the Dermatology Clinic, Boston Dispensary, the Evans Memorial Department of Clinical Research, Massachusetts Memorial Hospitals, and Departments of Medicine and Microbiology, Boston University School of Medicine, Boston University Medical Center, Boston, Mass.
-
This investigation was supported by a grant from the Medical Foundation, Inc., Boston, Mass.
-
- Received December 9, 1964.
- Accepted December 22, 1964.
